Cardiac involvement represents a critical prognostic factor in amyloidosis, as it represents a leading cause of morbidity and mortality, in primary light chain amyloidosis, in hereditary and also in wild-type transthyretin amyloidosis. A 54-year-old male was admitted to Emergency Room with complaints of dyspnea, palpitations and diaphoresis.
La Franca E, C.E. (2017). Amyloidosis and device therapy: an open debate. INTERNATIONAL ANGIOLOGY, 497-498 [10.23736/S0392-9590.17.03821-4].
Amyloidosis and device therapy: an open debate
La Franca E;Corrado E;Inga G;Ciaramitaro G;Novo S;Coppola G.
2017-01-01
Abstract
Cardiac involvement represents a critical prognostic factor in amyloidosis, as it represents a leading cause of morbidity and mortality, in primary light chain amyloidosis, in hereditary and also in wild-type transthyretin amyloidosis. A 54-year-old male was admitted to Emergency Room with complaints of dyspnea, palpitations and diaphoresis.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
amyloidosis 2017 (2).pdf
Solo gestori archvio
Dimensione
198.27 kB
Formato
Adobe PDF
|
198.27 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
